Skip to main content
. 2022 Mar 24;13:829228. doi: 10.3389/fimmu.2022.829228

Figure 4.

Figure 4

Kaplan Meier death-censored graft survival in the DSA+ cohort (BORTEJECT) in relation to (A) antibody-mediated rejection (ABMR) diagnosis, (B) KLRC2 genotype (KLRC2 wt/wt vs KLRC2 wt/del), and (C) the number of NKG2C and Fc gamma receptor (FcγR)IIIA ‘risk genotypes’ (KLRC2 wt/wt; FCGR3A-V/V158 or V/F158), respectively.